Greater Manchester Cancer Vanguard Innovation Establishing a Cancer Intelligence Service for Greater Manchester and Eastern Cheshire Worth noting in the spiel that this includes Cheshire East? 28 February 2017

Before we start… There are no planned fire drills Greater Manchester Cancer Before we start… Vanguard Innovation There are no planned fire drills Toilets are in the reception area on the right We will be taking photos – please let us know if you don’t want to be pictured Mobiles on silent please

Our team: Adrian Hackney – Project Lead Jac Livsey – Clinical Lead Greater Manchester Cancer Our team: Vanguard Innovation Adrian Hackney – Project Lead Jac Livsey – Clinical Lead Catherine O’Hara – Principal Analyst Nadeem Ahmed – Informatics Lead Darren Griffiths – Associate Director (Finance) Tracey Wright – Service Delivery Manager Jon Bruce – Senior Clinical Analyst Emeka Eze – Senior Clinical Analyst

This evening’s panel: Adrian Hackney – Project Lead Greater Manchester Cancer This evening’s panel: Vanguard Innovation Adrian Hackney – Project Lead Jac Livsey – Clinical Lead Frances Cox – I Want Great Care Catherine O’Hara – Principal Analyst Nadeem Ahmed – Informatics Lead

The national Cancer Vanguard Greater Manchester Cancer The national Cancer Vanguard Vanguard Innovation Single national Cancer Vanguard – ‘Accountable Clinical Network for Cancer’ – Greater Manchester Cancer Vanguard Innovation, Royal Marsden Partners & UCLH Cancer Collaborative Implementing ‘Achieving World Class Cancer Outcomes’ – to see radical improvements in cancer outcomes Aligning with local Sustainability and Transformation Planning (STP) and Cancer Board structures Population covered is over 10 million (2.8m in GM) Two-year programme testing new replicable models of cancer care delivery and commissioning – formally commenced in April 2016

What are we aiming to do? Provide cancer intelligence for Greater Manchester Cancer What are we aiming to do? Vanguard Innovation Provide cancer intelligence for 1) Patients and their families to help them make informed decisions and 2) Stakeholders to ensure the best possible delivery of, and access to, cancer services

What should the intelligence service deliver? Greater Manchester Cancer Vanguard Innovation What should the intelligence service deliver? Easy access to audience targeted information Locally relevant metrics and intelligence Population and sub-population specific measures and analyses Timely access to information Investigative analysis of trends and outliers Asking the right questions

How are going to deliver intelligence for our region? Greater Manchester Cancer Vanguard Innovation How are going to deliver intelligence for our region? PHE data sources Patient reported outcomes Local data sources

What questions are important to ask? Greater Manchester Cancer What questions are important to ask? Vanguard Innovation intelligence Clinical outcomes Provider performance Patient reported outcomes Patient experience % patients who lived at least one year after diagnosis? % treated within 62 days? % patients diagnosed at early stage? Compared to before your care or treatment, how would you rate your quality of life? How long have you been waiting for this appointment? Have you felt involved in the decisions made about your care?

What have we achieved so far? Greater Manchester Cancer What have we achieved so far? Vanguard Innovation Asking users about what they want – ongoing Dashboard design ideas Access to PHE data to enable locally relevant measures and intelligence Exploring access to local data sets iWantGreatCare

iWantGreatCare Greater Manchester Cancer Vanguard Innovation World’s largest patient review site – over 4 million patient reviews published Patient experience and outcomes in real time Reviews of individual clinicians, hospitals, community services, hospices, GP practices etc. Approx 100,000 new reviews every month Operating internationally in 23 countries, 18 languages Question sets developed and refined over 8 years to meet needs of patients and providers Involved in Cancer Vanguard since Feb 2016

iWGC & the Vanguard Greater Manchester Cancer Vanguard Innovation Questions applicable to each care setting that are easy to understand and to complete, providing the opportunity for patients and carers to provide feedback on care and treatment across all contact points. Questions devised to address some of the key indicators and outcomes of the Vanguard, such as: Respect for patient-centred values (including dignity, quality of life, shared decisions) Information and communication (on care and treatment and the involvement of family and friends) Coordination and integration of care across and within services Access to care, in particular the timeliness of access to services Demographics to enrich data analysis.   

Data collection and benchmarking Greater Manchester Cancer Data collection and benchmarking Vanguard Innovation New Vanguard question sets developed in consultation with stakeholders for: Acute setting Community setting Palliative Care Paediatrics All question sets have questions in common with each other and with the other questions asked by iWGC partners across the UK for cancer and non-cancer care. Ability to benchmark cancer services: By provider By care type By stage of patient journey Against general quality of care in the NHS   

Real-time data Greater Manchester Cancer Vanguard Innovation Reports will be available to staff real-time, and data analysis tools provided to deep dive the feedback:   

Greater Manchester Cancer Vanguard Innovation

Greater Manchester Cancer Vanguard Innovation Our next Showcase: CANCER PREVENTION 28 March 2017, from 5.15 pm until 6.15 pm The Blackett Theatre, Schuster Building, University of Manchester, Brunswick Street, Manchester M13 Vanguard Innovation Email: cancervanguard.gm.@nhs.net Web: gmcancervanguard.org Twitter: @GM_Ca_Vanguard